Understanding Diabetes: Types, Classification & Western vs. Traditional Chinese Medicine Approaches | CMCS

What Is Diabetes?

Diabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia (elevated blood glucose) resulting from defects in insulin secretion, insulin action, or both. Insulin, produced by the beta cells of the pancreas, is the key hormone that allows glucose to enter cells and be used for energy. When insulin is insufficient or ineffective, glucose accumulates in the bloodstream, causing the wide-ranging complications that define diabetes.

Diabetes is one of the world's most prevalent chronic diseases, affecting over 537 million adults globally (IDF 2021). China has the largest diabetic population in the world — approximately 140 million people — making diabetes management a major focus of Chinese medical expertise.

Classification of Diabetes: Understanding the Different Types

Diabetes is not a single disease. Accurate classification is essential because the underlying cause, treatment approach, and long-term prognosis differ significantly between types.

Type 1 Diabetes (T1D) — “1型糖尿病”

Type 1 diabetes is an autoimmune disease in which the body's immune system attacks and destroys the insulin-producing beta cells of the pancreas. The result is an absolute deficiency of insulin — the body produces little or none.

Key characteristics:

• Typically diagnosed in children, adolescents, or young adults (though it can occur at any age)
• Accounts for approximately 5–10% of all diabetes cases
• Onset is often rapid, with symptoms developing over days to weeks
• Patients are dependent on insulin for survival — without insulin, life-threatening diabetic ketoacidosis (DKA) develops
• Not caused by lifestyle factors; cannot be prevented
• Associated with other autoimmune conditions (thyroid disease, celiac disease)

Diagnosis: Positive autoantibodies (anti-GAD, anti-IA2, anti-ZnT8, anti-insulin antibodies) confirm autoimmune etiology. C-peptide levels are very low or undetectable, reflecting absent beta cell function.

Type 2 Diabetes (T2D) — “2型糖尿病”

Type 2 diabetes is the most common form, accounting for 90–95% of all diabetes cases. It is characterized by a combination of insulin resistance (cells do not respond normally to insulin) and progressive beta cell dysfunction (the pancreas gradually loses its ability to compensate by producing more insulin).

Key characteristics:

• Typically develops in adults over 40, though increasingly seen in younger people and even adolescents due to rising obesity rates
• Strongly associated with overweight/obesity, physical inactivity, unhealthy diet, and family history
• Onset is gradual; many patients are asymptomatic for years before diagnosis
• Can often be managed initially with lifestyle modification and oral medications; insulin may be required as the disease progresses
• Strongly preventable and modifiable through lifestyle changes

Diagnosis: C-peptide levels are normal or elevated (reflecting insulin resistance with compensatory hypersecretion) in early stages, declining as beta cell function deteriorates. Autoantibodies are negative.

Gestational Diabetes (GDM) — “妇娠期糖尿病”

Gestational diabetes is defined as glucose intolerance first recognized during pregnancy. It results from the insulin-resistant state of pregnancy overwhelming the pancreas's compensatory capacity.

Key characteristics:

• Affects approximately 7–14% of pregnancies worldwide; rates are higher in Asian populations
• Usually resolves after delivery, but significantly increases the mother's lifetime risk of developing Type 2 diabetes (up to 50% within 10 years)
• Associated with risks to the baby: macrosomia (large baby), neonatal hypoglycemia, increased risk of childhood obesity and diabetes
• Managed with dietary modification, blood glucose monitoring, and insulin if needed
• Requires careful postpartum follow-up and lifestyle modification to reduce future T2D risk

LADA — Latent Autoimmune Diabetes in Adults (“成人隐匈型自身免疫性糖尿病”)

LADA is a form of autoimmune diabetes that develops in adults (typically over 30) and progresses more slowly than classic Type 1 diabetes. It is frequently misdiagnosed as Type 2 diabetes because patients are adults and may initially respond to oral medications.

Key characteristics:

• Positive autoantibodies (especially anti-GAD), distinguishing it from Type 2
• Gradual progression to insulin dependence, typically within 5–6 years of diagnosis
• Often lean or normal weight (unlike typical Type 2)
• Accounts for approximately 5–10% of patients initially diagnosed with Type 2 diabetes
• Important to identify because treatment differs: sulfonylureas may accelerate beta cell destruction; insulin should be started earlier

MODY — Maturity-Onset Diabetes of the Young (“青少年发病的成人型糖尿病”)

MODY is a rare monogenic form of diabetes caused by mutations in single genes that affect beta cell function. It accounts for approximately 1–2% of diabetes cases but is frequently misdiagnosed as Type 1 or Type 2.

Key characteristics:

• Strong family history (autosomal dominant inheritance — affects multiple generations)
• Typically diagnosed before age 25
• Negative autoantibodies; variable C-peptide
• At least 14 subtypes (MODY1–14), each caused by a different gene mutation
• Treatment varies dramatically by subtype: MODY2 (GCK mutation) often requires no treatment; MODY3 (HNF1A mutation) responds exceptionally well to low-dose sulfonylureas; others may require insulin
• Genetic testing is required for definitive diagnosis

Secondary Diabetes

Diabetes can also arise secondary to other conditions or treatments:

• Pancreatogenic diabetes (Type 3c): Following pancreatitis, pancreatic surgery, or pancreatic cancer
• Steroid-induced diabetes: From prolonged corticosteroid use (see our article on corticosteroid dependence)
• Endocrine disorders: Cushing's syndrome, acromegaly, pheochromocytoma, hyperthyroidism
• Genetic syndromes: Down syndrome, Turner syndrome, Wolfram syndrome

Key Diagnostic Parameters

Accurate classification requires more than just measuring blood glucose. Key investigations include:

• Fasting plasma glucose (FPG): ≥ 7.0 mmol/L (126 mg/dL) on two occasions confirms diabetes
• HbA1c: ≥ 6.5% (48 mmol/mol) confirms diabetes; reflects average blood glucose over the preceding 2–3 months
• Oral glucose tolerance test (OGTT): 2-hour glucose ≥ 11.1 mmol/L (200 mg/dL) confirms diabetes
• C-peptide: Measures residual beta cell function; low in T1D/LADA, normal/high in early T2D
• Diabetes autoantibodies: Anti-GAD, anti-IA2, anti-ZnT8, anti-insulin; positive in T1D and LADA
• Genetic testing: Required for MODY diagnosis
• Fasting insulin / HOMA-IR: Assesses insulin resistance in T2D

Western Medicine Treatment Approaches

Western medicine (evidence-based medicine) approaches diabetes management through a structured framework targeting blood glucose control, cardiovascular risk reduction, and prevention of complications.

Type 1 Diabetes

• Insulin therapy (mandatory): Multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII / insulin pump)
• Continuous glucose monitoring (CGM): Real-time glucose tracking to optimize insulin dosing and reduce hypoglycemia
• Carbohydrate counting: Matching insulin doses to carbohydrate intake
• Closed-loop systems ("artificial pancreas"): Automated insulin delivery systems that adjust insulin in real time based on CGM data; increasingly available in China
• Islet cell transplantation: Available at select centers for patients with severe hypoglycemia unawareness

Type 2 Diabetes

Treatment follows a stepwise approach, starting with lifestyle modification and adding medications as needed:

• Lifestyle modification (foundation of all T2D treatment): Dietary changes (reduced refined carbohydrates, increased fiber, caloric restriction for weight loss), regular physical activity (150 minutes/week of moderate exercise), weight loss (even 5–10% weight loss significantly improves glycemic control)
• Metformin: First-line oral medication; reduces hepatic glucose production; weight-neutral; inexpensive; well-tolerated
• SGLT2 inhibitors (e.g., empagliflozin, dapagliflozin): Reduce glucose by increasing urinary glucose excretion; also have proven cardiovascular and renal protective effects; now recommended early in patients with heart failure or chronic kidney disease
• GLP-1 receptor agonists (e.g., semaglutide, liraglutide): Stimulate insulin secretion, suppress glucagon, slow gastric emptying, reduce appetite; significant weight loss benefit; proven cardiovascular protection; available as injections or oral tablets
• DPP-4 inhibitors (e.g., sitagliptin, saxagliptin): Enhance incretin effect; weight-neutral; well-tolerated
• Sulfonylureas (e.g., glipizide, gliclazide): Stimulate insulin secretion; inexpensive but risk of hypoglycemia and weight gain
• Insulin: Required when oral agents are insufficient; various regimens from basal insulin to full basal-bolus therapy
• Bariatric/metabolic surgery: For patients with BMI ≥ 32.5 (Asian threshold) and poorly controlled T2D; can achieve remission in 50–80% of patients

Complication Prevention and Management

Western medicine places strong emphasis on preventing and managing the long-term complications of diabetes:

• Cardiovascular disease: Blood pressure control (target < 130/80 mmHg), statin therapy, antiplatelet therapy, SGLT2 inhibitors and GLP-1 agonists for proven CV benefit
• Diabetic nephropathy: ACE inhibitors/ARBs for proteinuria, SGLT2 inhibitors for renal protection, careful blood pressure control
• Diabetic retinopathy: Annual ophthalmologic screening, laser photocoagulation, anti-VEGF injections for advanced disease
• Diabetic neuropathy: Optimal glucose control, pain management (duloxetine, pregabalin, gabapentin)
• Diabetic foot: Regular foot examination, podiatry care, prompt treatment of infections

Traditional Chinese Medicine (TCM) Approaches to Diabetes

In TCM, diabetes corresponds primarily to the concept of 消渴 (Xiāo Kě) — literally "wasting and thirsting" — a condition characterized by excessive thirst, frequent urination, and weight loss. TCM views diabetes not as a single disease but as a pattern of disharmony involving multiple organ systems, particularly the Lung, Stomach, and Kidney.

TCM Classification of Diabetes Patterns

TCM differentiates diabetes into patterns based on the predominant symptoms and underlying disharmony:

• Upper Xiao Ke (上消) — Lung Heat with Fluid Deficiency: Predominant symptom is excessive thirst and dry mouth; corresponds to Lung Yin deficiency with Heat; treated with herbs that clear Lung Heat and generate fluids (e.g., Tian Hua Fen, Mai Dong, Ge Gen)
• Middle Xiao Ke (中消) — Stomach Fire: Predominant symptom is excessive hunger and eating; corresponds to Stomach Fire consuming fluids; treated with herbs that clear Stomach Heat (e.g., Shi Gao, Zhi Mu, Huang Lian)
• Lower Xiao Ke (下消) — Kidney Deficiency: Predominant symptom is frequent, turbid urination; corresponds to Kidney Yin or Yang deficiency; treated with herbs that tonify Kidney Yin (e.g., Liu Wei Di Huang Wan) or Kidney Yang (e.g., Jin Gui Shen Qi Wan)

In practice, most patients present with mixed patterns, and TCM treatment is individualized based on the specific pattern diagnosis (辨证论治).

TCM Treatment Modalities for Diabetes

• Herbal medicine (中药): The cornerstone of TCM diabetes treatment. Commonly used herbs and formulas include:
  • Huang Qi (黄誁) — Astragalus; tonifies Qi, may improve insulin sensitivity
  • Huang Lian (黄连) — Coptis; contains berberine, which has demonstrated blood glucose-lowering effects in clinical trials comparable to metformin
  • Shan Yao (山药) — Chinese yam; tonifies Spleen and Kidney Yin
  • Tian Hua Fen (天花粉) — Trichosanthes root; generates fluids, clears Heat
  • Liu Wei Di Huang Wan (六味地黄丸) — Classic formula for Kidney Yin deficiency; widely used for lower Xiao Ke pattern
• Acupuncture (针灸): May help improve insulin sensitivity, reduce stress-related glucose elevation, and manage diabetic neuropathy pain; evidence is mixed but some studies show modest benefit as an adjunct to standard care
• Dietary therapy (食疗): TCM dietary recommendations for diabetes emphasize foods that clear Heat and generate fluids (bitter melon, lotus root, yam, mulberry) and avoid foods that generate Heat and Dampness (greasy, fried, sweet foods)
• Qigong and Tai Chi: Mind-body practices that may improve glycemic control, reduce stress, and improve quality of life; supported by several randomized controlled trials

Scientific Evidence for TCM in Diabetes

The most compelling evidence for TCM in diabetes comes from research on berberine, the active compound in Huang Lian (Coptis chinensis). Multiple randomized controlled trials have demonstrated that berberine:

• Reduces fasting blood glucose by approximately 20–30%
• Reduces HbA1c by approximately 0.9–1.5%
• Improves insulin sensitivity
• Has lipid-lowering effects comparable to statins
• Works through multiple mechanisms including AMPK activation (similar to metformin)

Berberine is now widely used in integrative diabetes management in China and is attracting significant international research interest. Other TCM compounds under active investigation include astragalus polysaccharides, bitter melon extracts, and mulberry leaf alkaloids.

Western Medicine vs. TCM: Key Differences in Approach

The Integrative Approach: Combining Western and TCM

Shanghai's leading academic medical centers offer a unique advantage: the ability to integrate Western evidence-based diabetes management with TCM expertise within a single healthcare system. This integrative approach is particularly valuable for:

• T2D patients who want to reduce medication burden through lifestyle and herbal adjuncts
• Patients with diabetic complications (neuropathy, nephropathy) where TCM may provide symptomatic relief alongside Western treatment
• Patients who have not achieved adequate glycemic control with Western medications alone
• Patients seeking a holistic approach that addresses both glucose control and overall wellbeing

Key specialists in Shanghai for diabetes management include Dr. Chen Haibing at Shanghai Tenth People's Hospital, and the renowned endocrinology department at Ruijin Hospital, which is one of China's leading centers for diabetes and metabolic disease research and treatment.

Who Should Consider Seeking Diabetes Care in Shanghai?

• Patients with uncertain diabetes type (possible LADA or MODY) requiring advanced diagnostic workup including autoantibody testing and genetic analysis
• Patients with poorly controlled T2D despite multiple medications, seeking optimization of their regimen
• Patients interested in metabolic surgery for T2D remission
• Patients with significant diabetic complications (nephropathy, retinopathy, neuropathy, foot disease) requiring specialist management
• Patients seeking an integrative Western + TCM approach to diabetes management
• Patients seeking a second opinion on their diabetes type, treatment plan, or complication management

What to Expect: Your Care Journey with CMCS

China Medical Concierge Shanghai (CMCS) coordinates specialist diabetes consultations, connecting you with the right endocrinologist, diabetologist, or integrative medicine specialist based on your specific needs.

1. Pre-arrival review: We review your diabetes history, current medications, recent HbA1c and glucose records, and complication status
2. Specialist matching: We identify the most appropriate specialist — endocrinology for complex type classification or complication management, integrative medicine for combined Western/TCM approaches
3. Appointment coordination: We schedule all consultations and investigations efficiently
4. Interpretation and translation: Our bilingual coordinators accompany you to all appointments
5. Comprehensive treatment plan: The specialist provides a detailed management plan with clear targets and follow-up recommendations

To discuss your case or request a consultation, contact us:

• 📧 contract@medicalsh.com
• 💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
• 🌐 www.medicalsh.com